Robert Geho is the founder of Diasome Pharmaceuticals. Diasome Pharmaceuticals has raised $25M in total funding. Latest round: Series C.
Robert Geho is the co-founder and CEO of Diasome Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing therapies for diabetes and obesity. He has guided the company through several funding rounds, including a Series C financing with participation from Eli Lilly and Company.
Full founder directory · Investor directory · Company funding database · Fundraising library